secwatch.observer — SEC 8-K summary
======================================

Issuer:     GYRE THERAPEUTICS, INC. (GYRE)
CIK:        0001124105
Form:       8-K
Filed at:   2026-08-26T13:00:44+00:00
Accession:  0001140361-26-034401
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gyre posts updated corporate presentation; no financial or clinical data disclosed
--------------------------------------------------------------------------------

- On Aug 26, 2026, Gyre Therapeutics, Inc. posted an updated corporate presentation to its website (Exhibit 99.1, dated August 2026).
- Presentation titled 'Building A New Protein Degrader Company For Unmet Medical Needs'; no financial or clinical data appear in the provided text.
- The exhibit text is truncated at a disclaimer page; no revenue, EPS, pipeline, or guidance figures are visible.
- No forward-looking statements, financial metrics, or clinical updates are included in the excerpt furnished.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1124105/000114036126034401/0001140361-26-034401-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1124105/000114036126034401/ef20081104_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-034401

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer